WC SACD One, Inc

Webster Equity Partners, based in Waltham, MA, is dedicated to delivering superior returns for its partners through investments in purpose-driven, patient-centric healthcare organizations. The firm focuses on identifying business models that provide exceptional clinical care and broad access to healthcare, aiming to improve patient outcomes. With a commitment to transparency, integrity, and teamwork, Webster Equity Partners collaborates with its portfolio companies to create long-term value through sustainable healthcare-focused business models. Their mission is to achieve top-quartile returns for investors while enhancing the performance of their investments. Generated from the website

J.W. Childs Associates is a private equity firm based in Boston. It specializes in leveraged buyouts and re-capitalization of middle-market growth companies. Since 1995, the company has invested in companies with a total transaction value of more than $7 billion. It invests through J.W. Childs Equity Partners III, an investment fund with total committed capital from financial institutions, pension funds, insurance companies and university endowments of $1.75 billion. The investment professionals at J.W. Childs combine backgrounds in both financial and operating disciplines. The company's financial partners have financial expertise and private equity investment experience, while its operating partners bring to bear complementary management and operating skills.

MedEquity Capital LLC is a private equity firm based in Waltham, MA, specializing in investments within the lower middle market healthcare sector. With a focus on companies that exhibit strong cash flow and growth potential, MedEquity leverages over 20 years of collective experience among its founders to drive successful investment strategies. The firm's expert team, each member possessing over 25 years of healthcare experience, emphasizes the importance of people and culture in achieving success. By partnering closely with management teams, MedEquity aims to unlock untapped organic growth and explore acquisition opportunities within their portfolio companies. Generated from the website